UC San Diego researchers have generated a new map of brain connectivity from a part of the brain called the basal ganglia, a hub for regulating motor and behavior functions. The breadth of connections revealed could potentially open avenues for intervention of Parkinson’s disease and other disorders
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
Neurobiologists have found that identifiable brain pathways are linked with specific debilitating symptoms of Parkinson’s disease. The findings could help form the basis for improving therapeutic strategies for precise symptoms of Parkinson’s at various levels of disease progression.
UC San Diego students will participate in nationwide clinical trial to assess if COVID-19 vaccination prevents infection and reduces risk of transmission.
Released today, the 2022 U.S. News Best Graduate Schools rankings gave high marks to UC San Diegos’s graduate education in political science and the Jacobs School of Engineering, among other professional schools and programs on campus.
Caroline Freund has been appointed the next dean of the University of California San Diego’s School of Global Policy and Strategy (GPS), effective July 1, 2021.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
